Elypta wins Nordic Life Science Award 2019

Ten life science companies, two from each Nordic country, were nominated for the Nordic Life Science Award 2019. Winners of the Academic Class and Business Class, both jury-evaluated, and Delegates’ Choice, or audience-evaluated, have finally been announced during Nordic Life Science Days (NLSDays).

Winner Company Class and Delegates’ Choice – Elypta

This year’s Company Award – and Delegates’ Choice Award – went to Elypta with the motivation: ‘for their achievement in combining distinguished science and technology to create a disruptive platform for the early detection of cancer. Elypta’s high-end technology holds the potential to greatly benefit patients by lowering the burden of disease and improving how cancer is currently managed, thus dramatically lowering health care costs.’

Jonas Ekstrand, Chairman of the Jury and NLSDays Program Director, was thrilled over the caliber of this year’s nominations.

– We have been privileged to evaluate such a select group of life science companies from all five Nordic countries, all of whom proved to uphold the innovative spirit and competence that the Nordics are known for.

Read the full press release from SwedenBio here.

Elypta is a portfolio company to Chalmers Ventures